Prosecution Insights
Last updated: April 19, 2026

Argenx BV

3 pending office actions

Portfolio Summary

3
Total Pending OAs
1
Final Rejections
2
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
19258059 VARIANT FC REGIONS TAYLOR, LIA ELAN 1641 Non-Final OA Jul 02, 2025
19243836 SUBCUTANEOUS FCRN ANTAGONIST FORMULATIONS AND METHODS OF USE THEREOF SULLIVAN, DENNIS JOHN 1642 Final Rejection Jun 20, 2025
18330903 ANTIBODIES TO HUMAN COMPLEMENT FACTOR C2b AND METHODS OF USE HADDAD, MAHER M 1641 Non-Final OA Jun 07, 2023

Managing Argenx BV's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month